Cargando…

Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

BACKGROUND: Recently it has been recognized that stromal markers could be used as a clinically relevant biomarker for therapy response and prognosis. Here, we report on a serum marker for stromal activation, A Disintegrin and Metalloprotease 12 (ADAM12) in colorectal cancer (CRC). METHODS: Using gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	ten Hoorn, Sanne, Waasdorp, Cynthia, van Oijen, Martijn G. H., Damhofer, Helene, Trinh, Anne, Zhao, Lan, Smits, Lisanne J. H., Bootsma, Sanne, van Pelt, Gabi W., Mesker, Wilma E., Mol, Linda, Goey, Kaitlyn K. H., Koopman, Miriam, Medema, Jan Paul, Tuynman, Jurriaan B., Zlobec, Inti, Punt, Cornelis J. A., Vermeulen, Louis, Bijlsma, Maarten F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004139/ https://www.ncbi.nlm.nih.gov/pubmed/35413826 http://dx.doi.org/10.1186/s12885-022-09436-0

Ejemplares similares

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
por: Ebbing, Eva A., et al.
Publicado: (2016)

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
por: Veenstra, V. L., et al.
Publicado: (2018)

Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data
por: Trinh, Anne, et al.
Publicado: (2018)

Stromal SPOCK1 supports invasive pancreatic cancer growth
por: Veenstra, Veronique L., et al.
Publicado: (2017)

Patched-2 functions to limit Patched-1 deficient skin cancer growth
por: Veenstra, Veronique L., et al.
Publicado: (2018)

Tumor stroma as contributing factor in the lymph node metastases process?
por: Mesker, Wilma E., et al.
Publicado: (2019)

The molecular biology of peritoneal metastatic disease
por: Bootsma, Sanne, et al.
Publicado: (2023)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials
por: Goey, Kaitlyn K H, et al.
Publicado: (2017)

ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
por: Maas, Sanne L., et al.
Publicado: (2023)

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2018)

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2019)

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
por: Smit, Marloes A, et al.
Publicado: (2021)

Local irradiation of patient-derived tumors in immunodeficient mice
por: van der Zalm, Amber P., et al.
Publicado: (2023)

N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment
por: Boyaval, Fanny, et al.
Publicado: (2021)

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
por: Smit, Marloes A., et al.
Publicado: (2021)

Numerical Study on the Autoignition of Biogas in Moderate or Intense Low Oxygen Dilution Nonpremixed Combustion Systems
por: Vasavan, Aromal, et al.
Publicado: (2018)

ADAM10-Mediated Cleavage of ICAM-1 Is Involved in Neutrophil Transendothelial Migration
por: Morsing, Sofia K. H., et al.
Publicado: (2021)

Standardization of the tumor-stroma ratio scoring method for breast cancer research
por: Hagenaars, Sophie C., et al.
Publicado: (2022)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

Molecular characterization of colorectal cancer related peritoneal metastatic disease
por: Lenos, Kristiaan J., et al.
Publicado: (2022)

A 5-D Implementation of FGM for the Large Eddy Simulation of a Stratified Swirled Flame with Heat Loss in a Gas Turbine Combustor
por: Donini, A., et al.
Publicado: (2016)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

The battle for prognosis at the invasive front of colorectal cancer
por: Lugli, Alessandro, et al.
Publicado: (2020)

Diagnostic variability in the histopathological assessment of advanced colorectal adenomas and early colorectal cancer in a screening population
por: Smits, Lisanne J H, et al.
Publicado: (2022)

Tumor Budding in Upper Gastrointestinal Carcinomas
por: Koelzer, Viktor H., et al.
Publicado: (2014)

Chromosomal copy number heterogeneity predicts survival rates across cancers
por: van Dijk, Erik, et al.
Publicado: (2021)

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
por: Hindriksen, Sanne, et al.
Publicado: (2012)

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
por: Vangangelt, Kiki M.H., et al.
Publicado: (2020)

Adam's Ancestors
por: Burr, H. S.
Publicado: (1935)

N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression
por: Holst, Stephanie, et al.
Publicado: (2016)

ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases
por: Sluiter, Nina R., et al.
Publicado: (2018)

ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
por: Sluiter, Nina Roelie, et al.
Publicado: (2018)

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)
por: Schokker, Sandor, et al.
Publicado: (2019)

Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
por: Dings, Mark P.G., et al.
Publicado: (2022)

Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types
por: Zlobec, Inti, et al.
Publicado: (2013)

Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneity
por: van Neerven, Sanne M., et al.
Publicado: (2015)

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
por: Coebergh van den Braak, R. R. J., et al.
Publicado: (2020)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
por: Smit, Marloes A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_udamp1sdnm01i94ud65vvp7dfr